M&T Bank Corp reduced its stake in shares of DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 3.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,588,926 shares of the basic materials company's stock after selling 61,549 shares during the quarter. M&T Bank Corp owned approximately 0.38% of DuPont de Nemours worth $63,874,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Salomon & Ludwin LLC lifted its stake in shares of DuPont de Nemours by 186.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company's stock worth $25,000 after purchasing an additional 207 shares during the last quarter. Palisade Asset Management LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth $26,000. Financial Life Planners purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth $27,000. Imprint Wealth LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth $27,000. Finally, Measured Wealth Private Client Group LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter worth $30,000. 73.96% of the stock is currently owned by hedge funds and other institutional investors.
DuPont de Nemours Trading Up 0.3%
Shares of NYSE:DD opened at $46.38 on Monday. The business's 50-day moving average is $46.49 and its 200 day moving average is $43.02. DuPont de Nemours, Inc. has a 1 year low of $26.82 and a 1 year high of $52.66. The firm has a market capitalization of $19.01 billion, a P/E ratio of -24.93, a P/E/G ratio of 1.60 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.42 and a quick ratio of 1.91.
DuPont de Nemours (NYSE:DD - Get Free Report) last announced its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.03. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The company had revenue of ($1,871.00) million for the quarter, compared to analyst estimates of $1.69 billion. During the same period in the prior year, the company posted $1.13 EPS. The firm's quarterly revenue was up .2% compared to the same quarter last year. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. On average, research analysts predict that DuPont de Nemours, Inc. will post 2.27 earnings per share for the current fiscal year.
DuPont de Nemours Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.7%. DuPont de Nemours's dividend payout ratio is currently -43.01%.
Analyst Ratings Changes
A number of brokerages recently weighed in on DD. Weiss Ratings restated a "sell (d)" rating on shares of DuPont de Nemours in a research note on Friday, March 27th. Royal Bank Of Canada decreased their price objective on DuPont de Nemours from $60.00 to $56.00 and set an "outperform" rating for the company in a research note on Friday, April 24th. Citigroup decreased their price objective on DuPont de Nemours from $59.00 to $56.00 and set a "buy" rating for the company in a research note on Monday, April 13th. BMO Capital Markets upped their price objective on DuPont de Nemours from $25.10 to $60.00 and gave the stock an "outperform" rating in a research note on Monday, April 13th. Finally, Wells Fargo & Company upped their target price on DuPont de Nemours from $50.00 to $55.00 and gave the company an "overweight" rating in a research report on Wednesday, February 11th. Twelve research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, DuPont de Nemours presently has a consensus rating of "Moderate Buy" and an average price target of $54.57.
Get Our Latest Stock Analysis on DuPont de Nemours
DuPont de Nemours Company Profile
(
Free Report)
DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.